FCF YoY
-58.27%
OCF YoY
-9.64%
Capex YoY
+53.93%
FCF Conversion Δ
-30.5 pp
Free cash flow bridge for Novo Nordisk (NVO) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Free cash flow: −43.33B DKK
FCF bridge breakdown for Novo Nordisk (NVO) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Free Cash Flow | 74.36B DKK | — |
| Operating Cash Flow | −12.65B DKK | -29.2% |
| Capital Expenditure | −30.68B DKK | -70.8% |
| Free Cash Flow | 31.03B DKK | — |
- Prior Free Cash Flow74.36B DKK
- Operating Cash Flow−12.65B DKK
- Capital Expenditure−30.68B DKK
- Free Cash Flow31.03B DKK
Identity check: drivers reconcile to ΔNI within 0.00 DKK ✓
Want to see how cash flow is built up?Cash Flow Waterfall
Frequently asked questions
Data & methodology
Novo Nordisk (NVO) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement